ABSTRACT
Purpose
Targeted delivery of aerosols could not only improve efficacy of inhaled drugs but also reduce side effects resulting from their accumulation in healthy tissue. Here we investigated the impact of magnetized aerosols on model drug accumulation and transgene expression in magnetically targeted lung regions of unanesthetized mice.
Methods
Solutions containing superparamagnetic iron oxide nanoparticles (SPIONs) and model drugs (fluorescein or complexed plasmid DNA) were nebulized to unanesthetized mice under the influence of an external magnetic gradient directed to the lungs. Drug accumulation and transgene expression was subsequently measured at different time points.
Results
We could demonstrate 2–3 fold higher accumulation of the model drug fluorescein and specific transgene expression in lung regions of mice which had been exposed to an external magnetic gradient during nebulization compared to the control mice without any exposure to magnetic gradient.
Conclusions
Magnetized aerosols present themselves as an efficient approach for targeted pulmonary delivery of drugs and gene therapeutic agents in order to treat localized diseases of the deeper airways.
Similar content being viewed by others
REFERENCES
Hershey AE, Kurzman ID, Forrest LJ, Bohling CA, Stonerook M, Placke ME, et al. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res. 1999;5(9):2653–9.
Hasenpusch G, Pfeifer C, Aneja MK, Wagner K, Reinhardt D, Gilon M et al. Aerosolized BC-819 inhibits primary but not secondary lung cancer growth. PloS one 6(6):e20760.
Aneja MK, Geiger JP, Himmel A, Rudolph C. Targeted gene delivery to the lung. Expet Opin Drug Deliv. 2009;6(6):567–83.
Elfinger M, Geiger J, Hasenpusch G, Uzgun S, Sieverling N, Aneja MK, et al. Targeting of the beta(2)-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo. J Contr Release. 2009;135(3):234–41.
Geiger J, Aneja MK, Hasenpusch G, Yuksekdag G, Kummerlowe G, Luy B, et al. Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analogues. Biomaterials. 2010;31(10):2903–11.
Dames P, Gleich B, Flemmer A, Hajek K, Seidl N, Wiekhorst F, et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol. 2007;2(8):495–9.
Heyder J. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc. 2004;1(4):315–20.
MacIntyre NR, Silver RM, Miller CW, Schuler F, Coleman RE. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med. 1985;13(2):81–4.
Rudolph C, Schillinger U, Ortiz A, Plank C, Golas MM, Sander B, et al. Aerosolized nanogram quantities of plasmid DNA mediate highly efficient gene delivery to mouse airway epithelium. Mol Ther. 2005;12(3):493–501.
Rudolph C, Ortiz A, Schillinger U, Jauernig J, Plank C, Rosenecker J. Methodological optimization of polyethylenimine (PEI)-based gene delivery to the lungs of mice via aerosol application. J Gene Med. 2005;7(1):59–66.
Rudolph C, Gleich B, Flemmer AW. Magnetic aerosol targeting of nanoparticles to cancer: nanomagnetosols. Meth Mol Cell Biol. 2010;624:267–80.
Koshkina NV, Knight V, Gilbert BE, Golunski E, Roberts L, Waldrep JC. Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO2-enriched air: pharmacokinetic studies. Canc Chemother Pharmacol. 2001;47(5):451–6.
Buckley SM, Howe SJ, Rahim AA, Buning H, McIntosh J, Wong SP, et al. Luciferin detection after intranasal vector delivery is improved by intranasal rather than intraperitoneal luciferin administration. Hum Gene Ther. 2008;19(10):1050–6.
Mykhaylyk O, Antequera YS, Vlaskou D, Plank C. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc. 2007;2(10):2391–411.
Wittgen BP, Kunst PW, van der Born K, van Wijk AW, Perkins W, Pilkiewicz FG, et al. Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung. Clin Cancer Res. 2007;13(8):2414–21.
Koshkina NV, Waldrep JC, Roberts LE, Golunski E, Melton S, Knight V. Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin Cancer Res. 2001;7(10):3258–62.
Tseng CL, Su WY, Yen KC, Yang KC, Lin FH. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials. 2009;30(20):3476–85.
Lehmann AD, Parak WJ, Zhang F, Ali Z, Rocker C, Nienhaus GU, et al. Fluorescent-magnetic hybrid nanoparticles induce a dose-dependent increase in proinflammatory response in lung cells in vitro correlated with intracellular localization. Small (Weinheim an der Bergstrasse, Germany). Small. 2010;6(6): 753–62.
Saito K, Shindo H, Ozuki T, Ishikawa A, Kotake F, Shimazaki Y, et al. Perfusion study of hypervascular hepatocellular carcinoma with SPIO. Magn Reson Med Sci. 2005;4(4):151–8.
Moller W, Barth W, Kohlhaufl M, Haussinger K, Stahlhofen W, Heyder J. Human alveolar long-term clearance of ferromagnetic iron oxide microparticles in healthy and diseased subjects. Exp Lung Res. 2001;27(7):547–68.
Moller W, Haussinger K, Winkler-Heil R, Stahlhofen W, Meyer T, Hofmann W, et al. Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects. J Appl Physiol. 2004;97(6):2200–6.
Moller W, Haussinger K, Ziegler-Heitbrock L, Heyder J. Mucociliary and long-term particle clearance in airways of patients with immotile cilia. Respir Res. 2006;7:10.
Alexiou C, Jurgons R, Schmid R, Erhardt W, Parak F, Bergemann C, et al. Magnetic Drug Targeting–a new approach in locoregional tumor therapy with chemotherapeutic agents. Experimental animal studies. HNO. 2005;53(7):618–22.
ACKNOWLEDGMENTS & DISCLOSURES
This work was supported by the BMBF BioFuture programme (FKZ0311898), the programme 13 N9182, LMUexcellent (Investitionsfonds), DFG RU 911/9-1 and Emma Thaler Foundation. Financial support by the German Research Foundation, through DFG Research Unit FOR917 (Project PL 281/3-1) and the German Federal Ministry of Education and Research through grant ELA 10/002 the German Excellence Cluster m4 ‘Nanosystems Initiative Munich’ awarded to Olga Mykhaylyk is greatfully acknowledged. We also thank Dr. W. Förster and Dr. T. Budiman (both TSE Systems, Bad Homburg, Germany) for technical and financial support of NOIS.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hasenpusch, G., Geiger, J., Wagner, K. et al. Magnetized Aerosols Comprising Superparamagnetic Iron Oxide Nanoparticles Improve Targeted Drug and Gene Delivery to the Lung. Pharm Res 29, 1308–1318 (2012). https://doi.org/10.1007/s11095-012-0682-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-012-0682-z